20-2816682-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001167670.3(TMEM239):c.128C>T(p.Pro43Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,543,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001167670.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM239 | NM_001167670.3 | c.128C>T | p.Pro43Leu | missense_variant | 2/2 | ENST00000380585.2 | NP_001161142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM239 | ENST00000380585.2 | c.128C>T | p.Pro43Leu | missense_variant | 2/2 | 1 | NM_001167670.3 | ENSP00000369959 | P1 | |
TMEM239 | ENST00000361033.1 | c.257C>T | p.Pro86Leu | missense_variant | 2/2 | 2 | ENSP00000354312 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000347 AC: 5AN: 144218Hom.: 0 AF XY: 0.0000389 AC XY: 3AN XY: 77022
GnomAD4 exome AF: 0.0000187 AC: 26AN: 1391412Hom.: 0 Cov.: 37 AF XY: 0.0000175 AC XY: 12AN XY: 686212
GnomAD4 genome AF: 0.000118 AC: 18AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.128C>T (p.P43L) alteration is located in exon 2 (coding exon 1) of the TMEM239 gene. This alteration results from a C to T substitution at nucleotide position 128, causing the proline (P) at amino acid position 43 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at